Summary : A good news is brewing for kids as the COVID-19 vaccine for the age group younger than 5 years old…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
Regulatory
-
-
RegulatorySanofiU.S FDA
FDA approves Enjaymo™ (sutimlimab-jome), First Treatment for use in Patients with Cold Agglutinin Disease
by adminby adminSummary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment…
-
GileadGlobal MarketPatentsRegulatory
Gilead’s Strong Financials Marred by $1.25B ViiV Patent Settlement
by adminby adminSummary : This week, Gilead Sciences took a $1.25 billion hit after reaching a settlement with ViiV Healthcare on a patent dispute…
-
Synopsis : The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment…
-
RegulatoryU.S FDA
Positive Phase III Data Lifts Madrigal, Hopes for an Effective NASH Treatment
by adminby adminSynopsis : Shares of Madrigal Pharmaceuticals went up in premarket trading after the company announced positive topline data from its Phase III…
-
Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine;…
-
Summary : Glenmark Pharmaceuticals on Friday said its US-based unit has received approval from the US health regulator to market Metronidazole Vaginal…
-
Summary : Union Minister for Chemicals and Fertilizers Mansukh Mandaviya today launched NIPER Research Portal along with Shri Bhagwanth Khuba, Minister of…
-
Global MarketRegulatoryU.S FDA
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
by adminby adminSynopsis : The U.S. Food and Drug Administration, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organizations have partnered…
-
Synopsis : Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of…